Q1 EPS Forecast for SAB Biotherapeutics Boosted by Analyst
SAB Biotherapeutics, Inc. (NASDAQ:SABS – Free Report) – HC Wainwright lifted their Q1 2025 earnings estimates for SAB Biotherapeutics in a research note issued on Tuesday, April 1st. HC Wainwright analyst E. White now expects that the company will earn ($1.14) per share for the quarter, up from their previous forecast of ($1.35). HC Wainwright […]
SAB Biotherapeutics, Inc. (NASDAQ:SABS – Free Report) – HC Wainwright lifted their Q1 2025 earnings estimates for SAB Biotherapeutics in a research note issued on Tuesday, April 1st. HC Wainwright analyst E. White now expects that the company will earn ($1.14) per share for the quarter, up from their previous forecast of ($1.35). HC Wainwright […]
